Variant · Snv
RFXANK NM_003721.4(RFXANK):c.712+4A>G
CI-VAR-00054614Explore in graph →NM_003721.4:c.712+4A>GClinVar 328647 rs73922830
Curated evidence
Evidence by cancer (0 items)
Grouped by cancer context first, then therapy. The same variant can be sensitizing in one cancer and irrelevant in another — contexts are never merged. 50 items per page; a cancer group may continue on the next page.
Data not yet available
No curated evidence item references this variant yet.
ClinVar
Clinical significance (1)
ClinVar interpretations are shown as structured records — significance, review status, star rating, conditions — never flattened into one word.
clinvarProvenance
- Source
- NCBI ClinVar (variant_summary)
- Dataset
- ClinVar variant_summary
- Version
- 2026-09-14
- Retrieved
- Sep 15, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- database
- License
- Public domain (US Government work, NCBI/NLM); acknowledgment requested
- Run
- ING-CLINVAR-20260915-000001
| Variation | Clinical significance | Review status | Stars | Conditions | Origin | Submitters | Last evaluated | Source |
|---|---|---|---|---|---|---|---|---|
| 328647 | Benign | criteria provided, multiple submitters, no conflicts | 2 | MHC class II deficiency; RFXANK-related disorder; Uterine corpus endometrial carcinoma; Clear cell carcinoma of kidney; Sarcoma; Ovarian serous cystadenocarcinoma; Lung cancer; Colon adenocarcinoma; Gastric cancer; Cervical cancer; Uterine carcinosarcoma; Thymoma; Acute myeloid leukemia; Nonpapillary renal cell carcinoma | germline | 4 | Feb 01, 2026 | clinvar |